The DOI matches its Crossref record; 120 of the 123 references it cites were found in a registry or an index.
Cortical inhibitory neurons and schizophrenia
Abstract
Impairments in certain cognitive functions, such as working memory, are core features of schizophrenia. Convergent findings indicate that a deficiency in signalling through the TrkB neurotrophin receptor leads to reduced GABA (gamma-aminobutyric acid) synthesis in the parvalbumin-containing subpopulation of inhibitory GABA neurons in the dorsolateral prefrontal cortex of individuals with schizophrenia. Despite both pre- and postsynaptic compensatory responses, the resulting alteration in perisomatic inhibition of pyramidal neurons contributes to a diminished capacity for the gamma-frequency synchronized neuronal activity that is required for working memory function. These findings reveal specific targets for therapeutic interventions to improve cognitive function in individuals with schizophrenia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Reduced expression of GAD67, the main GABA-synthesizing enzyme in the brain, appears to contribute to altered interneuron activity in psychosis [86,87] .”
From The traumagenic neurodevelopmental model of psychosis revisited (2014) · cites this paper as [86]
In the citing paper
“Certain classes of GABA interneurons are altered in individuals with psychosis, in particular reduced density in the anterior cingulate and reduced activity in the dorsolateral prefrontal cortex in the subpopulation expressing parvalbumin [84-86] .”
From The traumagenic neurodevelopmental model of psychosis revisited (2014) · cites this paper as [86]
In the citing paper
“Thus, the correct balance of inhibition and excitation seems to be critical for normative executive function, and conversely, disturbance of this balance is thought to be a fundamental component of psychiatric illness.69, 70”
From A role for synaptic plasticity in the adolescent development of executive function (2013) · cites this paper as [69]
In the citing paper
“Moreover, the expression of several GABA receptors and markers of inhibitory synapses are also altered in schizophrenia 50 .”
From Developmental timing and critical windows for the treatment of psychiatric disorders (2016) · cites this paper as [50]
In the citing paper
“Schizophrenia is increasingly recognized as a neurodevelopmental disorder that involves alterations in brain circuits, including dysfunction of parvalbumin (PV)-positive, fast-spiking GABA neurons (1, 2).”
From Prolonged Period of Cortical Plasticity upon Redox Dysregulation in Fast-Spiking Interneurons (2015) · cites this paper as [1]
In the citing paper
“its onset is linked to a potential disruption of the physiological maturation of inhibitory neural networks consisting of fast-spiking parvalbumin-positive gamma-aminobutric acid (GABAergic) interneurons”
From Perineuronal nets and schizophrenia: The importance of neuronal coatings (2014) · cites this paper as Lewis et al., 2005
In the citing paper
“Dysfunction and/or deficient inhibitory output from PV interneurons may be a common mechanism of multiple psychiatric disorders, such as schizophrenia (SCZ) (Lewis et al. 2005), autism spectrum disorders (ASD) (Gao and Penzes 2015) and bipolar disorder (BD) (Ruden et al. 2021).”
From Neuronal pentraxins as biomarkers of synaptic activity: from physiological functions to pathological changes in neurodegeneration (2022) · cites this paper as Lewis et al. 2005
In the citing paper
“Specifically, there is growing support for a hypothesis that cortical disinhibition occurs in schizophrenia, due to the disrupted functioning of inhibitory interneurons, which results in elevated E/I ratio (Lewis et al. 2005;Marin 2012).”
From Linking microcircuit dysfunction to cognitive impairment: Effects of disinhibition associated with schizophrenia in a cortical working memory model (2014) · cites this paper as Lewis et al. 2005
In the citing paper
“The prefrontal cortex is a key node in the distributed cortical network recruited during WM (Owen et al. 2005;Fuster 2008) and exhibits altered inhibitory microcircuitry in schizophrenia (Lewis et al. 2005;Bitanihirwe et al. 2009).”
From Linking microcircuit dysfunction to cognitive impairment: Effects of disinhibition associated with schizophrenia in a cortical working memory model (2014) · cites this paper as Lewis et al. 2005
In the citing paper
“Elevated prefrontal E/I ratio may result from alterations in multiple pathways that are implicated in schizophrenia.These include GABAergic deficits, such as reduced GAD67 production (Lewis et al. 2005); increased background input from other areas such as the thalamus or hippocampus (Lisman et al. 2008); or abnormal levels of neuromodulators (Laruelle et al. 2003).”
From Linking microcircuit dysfunction to cognitive impairment: Effects of disinhibition associated with schizophrenia in a cortical working memory model (2014) · cites this paper as Lewis et al. 2005
In the citing paper
“Both interneuron cell classes are altered in schizophrenia (Lewis et al. 2005;Morris et al. 2008;Bitanihirwe et al. 2009).”
From Linking microcircuit dysfunction to cognitive impairment: Effects of disinhibition associated with schizophrenia in a cortical working memory model (2014) · cites this paper as Lewis et al. 2005
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
An Integrative Theory of Prefrontal Cortex Function
Miller, E. K., & Cohen, J. D. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.167 · Cited by 12,803
What are the functional consequences of neurocognitive deficits in schizophrenia?
(1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.3.321 · Cited by 3,516
Interneurons of the neocortical inhibitory system
Markram, H., Toledo-Rodriguez, M., Wang, Y., Gupta, A., Silberberg, G., & Wu, C. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1519 · Cited by 2,954
Cellular basis of working memory
Goldman-Rakic, P. S. (1995) · Neuron · doi:10.1016/0896-6273(95)90304-6 · Cited by 2,663
Physiologic Dysfunction of Dorsolateral Prefrontal Cortex in Schizophrenia
Weinberger, D. R. (1986) · Archives of General Psychiatry · doi:10.1001/archpsyc.1986.01800020020004 · Cited by 2,025
Principles of Frontal Lobe Function
Stuss, D. T. (2002) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195134971.001.0001 · Cited by 1,731
Topography Of Cognition: Parallel Distributed Networks In Primate Association Cortex
Goldman‐Rakic, P. S. (1988) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.11.030188.001033 · Cited by 1,658
Decreased Dendritic Spine Density on Prefrontal Cortical Pyramidal Neurons in Schizophrenia
Glantz, L. A., & Lewis, D. A. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.1.65 · Cited by 1,636
Self-citationSynchronization of neuronal activity in hippocampus by individual GABAergic interneurons
Cobb, S. R., Buhl, E. H., Halasy, K., Paulsen, O., & Somogyi, P. (1995) · Nature · doi:10.1038/378075a0 · Cited by 1,498
Flagged first, then by citations
3 of the 123 references couldn’t be matched to a known paper.
Research works printed but not linked: 2
- Konopaske, G. T., Sweet, R. A. & Lewis, D. A. GABA transporter-1 immunoreactivity in auditory association cortex in schizophrenia. Soc. Neurosci. Abstr. 34, 110.11 (2004).
- Peters, A. in Cerebral Cortex Vol. 1 (eds Jones, E. G. & Peters, A.) 361–380 (Plenum, New York, 1984).
Cited by
Sorted by citations
Items 501–600 of 1,012
Evidence for inhibitory deficits in the prefrontal cortex in schizophrenia
Radhu, N., Dominguez, L. G., Farzan, F., Richter, M. A., Semeralul, M. O., Chen, R. E., Fitzgerald, P. B., & Daskalakis, Z. J. (2014) · Brain · doi:10.1093/brain/awu360 · Cited by 106
Fumagalli, F., Pasquale, L. D., Caffino, L., Racagni, G., & Riva, M. A. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05918.x · Cited by 100
Cea-del Rio, C. A., Lawrence, J. J., Tricoire, L., Erdelyi, F., Szabo, G., & McBain, C. J. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.5040-09.2010 · Cited by 99
Adams, R. A., Pinotsis, D., Tsirlis, K., Unruh, L., Mahajan, A., Horas, A. M., Convertino, L., Summerfelt, A., Sampath, H., Du, X. M., et al. (2022) · Biological Psychiatry · doi:10.1016/j.biopsych.2021.07.024 · Cited by 98
Time and space profiling of NMDA receptor co‐agonist functions
Mothet, J., Bail, M. L., & Billard, J. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13204 · Cited by 103
Nasyrova, R. F., Ivashchenko, D. V., Ivanov, M. V., & Незнанов, Н. Г. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2015.00139 · Cited by 98
Two distinct activity patterns of fast-spiking interneurons during neocortical UP states
Puig, M. V., Ushimaru, M., & Kawaguchi, Y. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712219105 · Cited by 101
Increased cortical inhibition in persons with schizophrenia treated with clozapine
Daskalakis, Z. J., Christensen, B. K., Fitzgerald, P. B., Möller, B., FOUNTAIN, S., & Chen, R. E. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881107084002 · Cited by 99
Revisiting Thyroid Hormones in Schizophrenia
Santos, N. C., Costa, P., Ruano, D., Macedo, A., Soares, M. J., Valente, J., Pereira, A. T., Azevedo, M. H., & Palha, J. A. (2012) · Journal of Thyroid Research · doi:10.1155/2012/569147 · Cited by 97
Biological hypotheses, risk factors, and biomarkers of schizophrenia
Fišar, Z. (2022) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2022.110626 · Cited by 103
Meechan, D. W., Maynard, T. M., Tucker, E. S., Fernandez, A., Karpinski, B. A., Rothblat, L. A., & LaMantia, A. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.03.004 · Cited by 105
Gamma oscillation deficits and the onset and early progression of schizophrenia
Woo, T.-U. W., Spencer, K., & McCarley, R. W. (2010) · Harvard Review of Psychiatry · doi:10.3109/10673221003747609 · Cited by 96
Serotonergic Mechanisms as Targets for Existing and Novel Antipsychotics
Meltzer, H. Y. (2012) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-25761-2_4 · Cited by 97
Joshi, D., Fung, S. J., Rothwell, A. R., & Weickert, C. S. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.06.021 · Cited by 96
Retinoic Acid Functions as a Key GABAergic Differentiation Signal in the Basal Ganglia
Chatzi, C. A., Brade, T., & Duester, G. (2011) · PLoS Biology · doi:10.1371/journal.pbio.1000609 · Cited by 96
Sun, L., Castellanos, N., Grützner, C., Koethe, D., Rivolta, D., Wibral, M., Kranaster, L., Singer, W., Leweke, M. F., & Uhlhaas, P. J. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.08.023 · Cited by 96
Brand, S., Moller, M., & Harvey, B. (2015) · Current Neuropharmacology · doi:10.2174/1570159x13666150307004545 · Cited by 95
Perineuronal nets and schizophrenia: The importance of neuronal coatings
Bitanihirwe, B. K. Y., & Woo, T.-U. W. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.03.018 · Cited by 95
Schubert, K. O., Föcking, M., & Cotter, D. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.02.002 · Cited by 96
Guilarte, T. R., Opler, M. G., & Pletnikov, M. V. (2011) · NeuroToxicology · doi:10.1016/j.neuro.2011.11.008 · Cited by 97
Parikh, V., Kutlu, M. G., & Gould, T. J. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.01.020 · Cited by 97
Ketamine: differential neurophysiological dynamics in functional networks in the rat brain
Ahnaou, A., Huysmans, H., Biermans, R., Manyakov, N. V., & Drinkenburg, W. H. I. M. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.198 · Cited by 97
Barr, M. S., Farzan, F., Arenovich, T., Chen, R. E., Fitzgerald, P. B., & Daskalakis, Z. J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022627 · Cited by 96
Schultze‐Lutter, F., Debbané, M., Theodoridou, A., Wood, S. J., Raballo, A., Michel, C., Schmidt, S. J., Kindler, J., Ruhrmann, S., & Uhlhaas, P. J. (2016) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2016.00009 · Cited by 98
Krawchuk, M. B., Ruff, C. F., Yang, X., Ross, S. E., & Vazquez, A. L. (2019) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x19870105 · Cited by 94
Diversity and Function of Somatostatin-Expressing Interneurons in the Cerebral Cortex
Riedemann, T. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20122952 · Cited by 103
Nagahama, K., Sakoori, K., Watanabe, T., Kishi, Y., Kawaji, K., Koebis, M., Nakao, K., Gotoh, Y., Aiba, A., Uesaka, N., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108126 · Cited by 89
Piontkewitz, Y., Bernstein, H., Dobrowolny, H., Bogerts, B., Weiner, I., & Keilhoff, G. (2011) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2011.11.004 · Cited by 93
Kocsis, B., Brown, R. E., McCarley, R. W., & Hajós, M. (2013) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12081 · Cited by 96
Origins of strabismus and loss of binocular vision
Quoc, E. B., & Milleret, C. (2014) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2014.00071 · Cited by 93
Dong, E., Ruzicka, W. B., Grayson, D. R., & Guidotti, A. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.10.030 · Cited by 98
Sex differences and the role of estrogen in animal models of schizophrenia: Interaction with BDNF
Wu, Y. C., Hill, R., Gogos, A., & van den Buuse, M. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.10.024 · Cited by 95
Molecular substrates of schizophrenia: homeostatic signaling to connectivity
Landek‐Salgado, M. A., Faust, T. E., & Sawa, A. (2015) · Molecular Psychiatry · doi:10.1038/mp.2015.141 · Cited by 95
Tang, A.-H., Karson, M. A., Nagode, D. A., McIntosh, J. M., Uebele, V. N., Renger, J. J., Klugmann, M., Milner, T. A., & Alger, B. E. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.2781-11.2011 · Cited by 92
Cell biology of BDNF and its relevance to schizophrenia
Lu, B., & Martinowich, K. (2008) · Novartis Foundation Symposia · doi:10.1002/9780470751251.ch10 · Cited by 92
Prolonged Period of Cortical Plasticity upon Redox Dysregulation in Fast-Spiking Interneurons
Morishita, H., Cabungcal, J.-H., Chen, Y., Do, K. Q., & Hensch, T. K. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.12.026 · Cited by 92
Organization and maintenance of molecular domains in myelinated axons
Buttermore, E. D., Thaxton, C., & Bhat, M. A. (2013) · Journal of Neuroscience Research · doi:10.1002/jnr.23197 · Cited by 96
Cognition in transmembrane domain neuregulin 1 mutant mice
Duffy, L., Cappas, E., Lai, D., Boucher, A. A., & Karl, T. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.07.042 · Cited by 95
Sorce, S., Schiavone, S., Tucci, P., Colaianna, M., Jaquet, V., Cuomo, V., Dubois‐Dauphin, M., Trabace, L., & Krause, K. H. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.1491-10.2010 · Cited by 93
Rass, O., Forsyth, J. K., Krishnan, G. P., Hetrick, W. P., Klaunig, M. J., Breier, A. F., O’Donnell, B. F., & Brenner, C. A. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.01.003 · Cited by 92
Kimoto, S., Bazmi, H. H., & Lewis, D. A. (2014) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2014.14010004 · Cited by 91
Self-citationGomes, F. V., Zhu, X., & Grace, A. A. (2020) · Molecular Psychiatry · doi:10.1038/s41380-019-0514-1 · Cited by 91
Maldonado-Avilés, J. G., Curley, A. A., Hashimoto, T., Morrow, A. L., Ramsey, A. J., O’Donnell, P., Volk, D. W., & Lewis, D. A. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.08101484 · Cited by 91
Self-citationNMDA Receptor Internalization by Autoantibodies: A Reversible Mechanism Underlying Psychosis?
Masdeu, J. C., Dalmau, J. O., & Berman, K. F. (2016) · Trends in Neurosciences · doi:10.1016/j.tins.2016.02.006 · Cited by 92
Epigenetic Regulation of the Social Brain
Bludau, A., Royer, M., Meister, G., Neumann, I. D., & Menon, R. (2019) · Trends in Neurosciences · doi:10.1016/j.tins.2019.04.001 · Cited by 92
Kulak, A., Cuenod, M., & Do, K. Q. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.10.020 · Cited by 90
Schizophrenia genetics: uncovering positional candidate genes
Karayiorgou, M., & Gogos, J. A. (2006) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201587 · Cited by 90
Neuregulin signaling, cortical circuitry development and schizophrenia
Rico, B., & Marín, Ó. (2011) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2010.12.010 · Cited by 92
Schizophrenia as a Disorder of Molecular Pathways
Horváth, S., & Mirnics, K. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.01.001 · Cited by 90
Hong, J., & Bang, M. (2020) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2020.18.1.10 · Cited by 90
Dysregulation of GABAergic Neurotransmission in Mood Disorders
Bielau, H., Steiner, J. H., Mawrin, C., Trübner, K., Brisch, R., Meyer-Lotz, G., Brodhun, M., Dobrowolny, H., Baumann, B., Gos, T., et al. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1397.081 · Cited by 90
Nishijo, M., Pham, T. T., Nguyen, A. T. N., Tran, N. N., Nakagawa, H., Hoang, L. V., Tran, A. H., Morikawa, Y., Ho, M. D., Kido, T., et al. (2014) · Molecular Psychiatry · doi:10.1038/mp.2014.18 · Cited by 90
Reduced cortical inhibition in first-episode schizophrenia
Wobrock, T., Schneider, M., Kadovic, D., Schneider-Axmann, T., Ecker, U. K. H., Retz, W., Rösler, M., & Falkai, P. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.06.001 · Cited by 91
Renal expression of parvalbumin is critical for NaCl handling and response to diuretics
Belge, H., Gailly, P. L., Schwaller, B., Loffing, J., Debaix, H., Riveira‐Muñoz, E., Beauwens, R., Devogelaer, J., Hoenderop, J. G. J., Bindels, R. J. M., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702810104 · Cited by 90
Gomes, F. V., Issy, A. C., Ferreira, F. R., Viveros, M.-P., Del Bel, E. A., & Guimarães, F. S. (2015) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyu041 · Cited by 89
GABA through the Ages: Regulation of Cortical Function and Plasticity by Inhibitory Interneurons
Lehmann, K., Steinecke, A., & Bolz, J. (2012) · Neural Plasticity · doi:10.1155/2012/892784 · Cited by 94
Test-Retest Reliability of the 40 Hz EEG Auditory Steady-State Response
Legget, K. T., Steinmetz, S. E., Carroll, A. M., Simon, S. T., Wallace, A., & Rojas, D. C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085748 · Cited by 93
Molecular mechanisms underlying glutamatergic dysfunction in schizophrenia: therapeutic implications
Gaspar, P. A., Bustamante, M. L., Hernán Silva, I., & Aboitiz, F. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06325.x · Cited by 91
The Early Fetal Development of Human Neocortical GABAergic Interneurons
Al‐Jaberi, N., Lindsay, S., Sarma, S., Bayatti, N., & Clowry, G. J. (2013) · Cerebral Cortex · doi:10.1093/cercor/bht254 · Cited by 92
Wu, Y. C., Du, X., van den Buuse, M., & Hill, R. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.03.016 · Cited by 89
Firing Frequency Maxima of Fast-Spiking Neurons in Human, Monkey, and Mouse Neocortex
Wang, B., Wei, K., Guang, J., Chen, G., Yin, L., Deng, S., He, Q., Liu, Y., He, T., Zheng, R., et al. (2016) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00239 · Cited by 95
Massi, L., Lagler, M., Hartwich, K., Borhegyi, Z., Somogyi, P., & Klausberger, T. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.3475-12.2012 · Cited by 88
de la Fuente‐Sandoval, C., Reyes-Madrigal, F., Mao, X., León-Ortíz, P., Rodríguez-Mayoral, O., Solís‐Vivanco, R., Favila, R., Graff‐Guerrero, A., & Shungu, D. C. (2015) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyv105 · Cited by 89
Reelin down-regulation in mice and psychosis endophenotypes
Tueting, P. A., Doueiri, M.-S., Guidotti, A., DAVIS, J., & Costa, E. (2006) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2006.04.001 · Cited by 91
Kleinman, J. E., Law, A. J., Lipska, B. K., Hyde, T. M., Ellis, J. K., Harrison, P. J., & Weinberger, D. R. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.10.032 · Cited by 89
Components of Cross-Frequency Modulation in Health and Disease
Allen, E. A., Liu, J., Kiehl, K. A., Gelernter, J. E., Pearlson, G. D., Perrone‐Bizzozero, N. I., & Calhoun, V. D. (2011) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2011.00059 · Cited by 90
Altered Global Signal Topography in Schizophrenia
Yang, G., Murray, J. D., Glasser, M. F., Pearlson, G. D., Krystal, J. H., Schleifer, C., Repovš, G., & Anticevic, A. (2016) · Cerebral Cortex · doi:10.1093/cercor/bhw297 · Cited by 88
Estrogens and the cognitive symptoms of schizophrenia: Possible neuroprotective mechanisms
McGregor, C., Riordan, A. J., & Thornton, J. E. (2017) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2017.06.003 · Cited by 90
Perisomatic inhibition and cortical circuit dysfunction in schizophrenia
Lewis, D. A., Fish, K. N., Arion, D., & Gonzalez-Burgos, G. (2011) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2011.05.013 · Cited by 87
Self-citationMolecular Profiles of Pyramidal Neurons in the Superior Temporal Cortex in Schizophrenia
Pietersen, C. Y., Mauney, S. A., Kim, S. S., Lim, M. P., Rooney, R. J., Goldstein, J. M., Petryshen, T. L., Seidman, L. J., Shenton, M. E., McCarley, R. W., et al. (2014) · Journal of Neurogenetics · doi:10.3109/01677063.2014.882918 · Cited by 87
Shah, A., & Lodge, D. J. (2013) · Translational Psychiatry · doi:10.1038/tp.2012.145 · Cited by 87
Allosteric Modulators for the Treatment of Schizophrenia: Targeting Glutamatergic Networks
Menniti, F. S., Lindsley, C. W., Conn, P. J., Pandit, J., Zagouras, P., & Volkmann, R. A. (2013) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026611313010005 · Cited by 87
GABA—from Inhibition to Cognition: Emerging Concepts
Schmidt‐Wilcke, T., Fuchs, E., Funke, K., Vlachos, A., Müller‐Dahlhaus, F., Puts, N. A. J., Harris, R. E., & Edden, R. A. E. (2017) · The Neuroscientist · doi:10.1177/1073858417734530 · Cited by 93
One-carbon metabolism and schizophrenia: current challenges and future directions
Krebs, M., Bellon, A., Mainguy, G., Jay, T. M., & Frieling, H. (2009) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2009.10.001 · Cited by 89
Wieck, A., Andersen, S. L., & Brenhouse, H. C. (2012) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2012.11.012 · Cited by 88
Léger, M., & Neill, J. C. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.06.029 · Cited by 92
Stolp, H. B., Neuhaus, A. A., Sundramoorthi, R., & Molnár, Z. (2012) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2012.00050 · Cited by 91
Ephrin‐A5 acts as a repulsive cue for migrating cortical interneurons
Zimmer‐Bensch, G., Garcez, P. P., Rudolph, J., Niehage, R., Weth, F., Lent, R., & Bolz, J. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06320.x · Cited by 93
Rogasch, N. C., Daskalakis, Z. J., & Fitzgerald, P. B. (2013) · Schizophrenia Bulletin · doi:10.1093/schbul/sbt078 · Cited by 91
Modeling psychiatric disorders with patient-derived iPSCs
Wen, Z., Christian, K. M., Song, H., & Ming, G.-L. (2016) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2015.11.003 · Cited by 84
Park, B., Bethlehem, R. A. I., Paquola, C., Larivière, S., Rodríguez‐Cruces, R., de Wael, R. V., Bullmore, E. T., Dolan, R. J., Goodyer, I. M., Fonagy, P., et al. (2021) · eLife · doi:10.7554/elife.64694 · Cited by 86
Reduced mediodorsal thalamic volume and prefrontal cortical spindle activity in schizophrenia
Buchmann, A., Dentico, D., Peterson, M. J., Riedner, B. A., Sarasso, S., Massimini, M., Tononi, G., & Ferrarelli, F. (2014) · NeuroImage · doi:10.1016/j.neuroimage.2014.08.017 · Cited by 84
Gaetz, W. C., Roberts, T. P. L., Singh, K. D., & Muthukumaraswamy, S. D. (2011) · Human Brain Mapping · doi:10.1002/hbm.21339 · Cited by 88
Perez, S. M., & Lodge, D. J. (2013) · Molecular Psychiatry · doi:10.1038/mp.2013.111 · Cited by 87
Dejaegere, T., Serneels, L., Schäfer, M., Biervliet, J. V., Horré, K., Depboylu, C., Alvarez‐Fischer, D., Herreman, A., Willem, M., Haass, C., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800507105 · Cited by 85
Richetto, J., Calabrese, F., Meyer, U., & Riva, M. A. (2013) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2013.07.006 · Cited by 84
Johnston, K., DeSouza, J. F. X., & Everling, S. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.5953-08.2009 · Cited by 84
DNA Damage and Repair in Schizophrenia and Autism: Implications for Cancer Comorbidity and Beyond
Markkanen, E., Meyer, U., & Dianov, G. L. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17060856 · Cited by 84
Jeevakumar, V., Driskill, C., Paine, A., Sobhanian, M., Vakil, H., Morris, B., Ramos, J., & Kroener, S. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.01.010 · Cited by 84
Changes in parvalbumin immunoreactivity with aging in the central auditory system of the rat.
Ouda, L., Druga, R., & Syka, J. (2008) · Experimental Gerontology · doi:10.1016/j.exger.2008.04.001 · Cited by 83
Hioki, H., Okamoto, S., Konno, M., Kameda, H., Sohn, J., Kuramoto, E., Fujiyama, F., & Kaneko, T. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.2255-12.2013 · Cited by 83
Guan, J., Cai, J. J., Ji, G., & Sham, P. C. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0488-4 · Cited by 86
Veit, J., Handy, G., Mossing, D. P., Doiron, B., & Adesnik, H. (2022) · Neuron · doi:10.1016/j.neuron.2022.10.036 · Cited by 84
Functional myelin in cognition and neurodevelopmental disorders
Khelfaoui, H., Ibaceta-González, C., & Angulo, M. C. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05222-2 · Cited by 87
Schizophrenia-Like Attentional Deficits Following Blockade of Prefrontal Cortex GABAA Receptors
Paine, T. A., Slipp, L. E., & Carlezon, W. A. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.51 · Cited by 85
Ouellet, L., & de Villers‐Sidani, E. (2014) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2014.00040 · Cited by 87
Cabungcal, J.-H., Preissmann, D., Delseth, C., Cuénod, M., Kim, Q., & Schenk, F. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.03.001 · Cited by 83
Novel Benzodiazepine-Like Ligands with Various Anxiolytic, Antidepressant, or Pro-Cognitive Profiles
Prévot, T. D., Li, G., Vidojević, A., Misquitta, K. A., Fee, C., Santrač, A., Knutson, D. E., Stephen, M. R., Kodali, R., Zahn, N. M., et al. (2019) · Complex Psychiatry · doi:10.1159/000496086 · Cited by 86
Environmental regulation of the neural epigenome
Caldji, C., Hellstrom, I. C., Zhang, T.-Y., Diorio, J., & Meaney, M. J. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.03.032 · Cited by 82
Modulation of Synaptic Plasticity in the Cortex Needs to Understand All the Players
Meunier, C. N. J., Chameau, P. J. P., & Fossier, P. (2017) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2017.00002 · Cited by 86
Metadata
- Authors
- Lewis, D. A., Hashimoto, T., & Volk, D. W.
- Affiliations
- University of Pittsburgh (US)
- Corresponding author
- Lewis, David A.
- Venue
- Nature Reviews Neuroscience
- Published
- 2005-04
- Volume
- 6
- Issue
- 4
- Pages
- 312-324
- ISSN
- 1471-003X (ISSN-L)
- 1471-0048
- OpenAlex
- W2089912569
- Cited by
- 2,297
- References
- 123
- Citations by year
- 2026: 36 · 2025: 51 · 2024: 63 · 2023: 48 · 2022: 70 · 2021: 86 · 2020: 77 · 2019: 94 · 2018: 102 · 2017: 89 · 2016: 123 · 2015: 148 · 2014: 132 · 2013: 167 · 2012: 151
- FWCI
- 16.54
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Alliance for Research on Schizophrenia and Depression
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- schizophrenia, cortical inhibitory neurons, parvalbumin interneurons, GABA synthesis, dorsolateral prefrontal cortex, working memory, perisomatic inhibition, cognitive impairment
- MeSH terms
- Animals, Cerebral Cortex, Humans, Nerve Net, Neural Inhibition, Neurons, Schizophrenia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
